NCT04847843

Brief Summary

The overall objective of this study is to evaluate the efficacy of a mindfulness-based intervention to prevent weight regain in weight-reduced adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

June 16, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

November 25, 2025

Completed
Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

1.9 years

First QC Date

April 13, 2021

Results QC Date

July 28, 2025

Last Update Submit

November 21, 2025

Conditions

Keywords

Appetite RegulationWeight regain preventionWeight loss maintenancemindfulnessmindfulness orientated recovery enhancement

Outcome Measures

Primary Outcomes (1)

  • Changes in Body Weight

    Body weight (kg) measured using a calibrated digital scale at three time points: baseline and 6 month follow up. Outcome measure was calculated by subtracting baseline weight from 6 month weigh. Lower value indicates greater weight loss.

    Baseline and 6 month follow up

Secondary Outcomes (5)

  • Ways of Savoring Checklist (WOSC).

    6-month follow-up

  • Dietary Restraint

    6 month follow up

  • Dietary Disinhibition

    6 month follow-up

  • Interoceptive Awareness

    6 month follow up

  • Hedonic Hunger

    6 months

Study Arms (2)

Mindfulness Orientated Recovery Enhancement (MORE) Intervention

EXPERIMENTAL

8-week MORE intervention adapted for preventing weight regain

Behavioral: Mindfulness Orientated Recovery Enhancement

Control Intervention

ACTIVE COMPARATOR

8-week control intervention based on the Diabetes Prevention Program's Prevent T2 for Life program.

Behavioral: Control Intervention

Interventions

The MORE curriculum has been adapted for this intervention to address food intake behaviors and will provide training in mindfulness techniques to increase awareness of, and self-control over, cravings; reappraisal skills to promote emotion regulation and restructure motivations for highly palatable food intake; and savoring pleasant events and emotions to overcome defects in natural reward processing.

Also known as: MORE
Mindfulness Orientated Recovery Enhancement (MORE) Intervention

The curriculum will be based on the Diabetes Prevention Program's Prevent T2 for Life program, which is an evidence-based national healthful lifestyle maintenance intervention. This program includes training in healthful eating, meal planning, and recipe modification; time and stress management; adapting lifestyle habits for continued success during holidays, vacations, and other special situations; and relapse prevention.

Control Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65
  • Bariatric Surgery patients: 12-18 months post-operation.
  • Medical weight loss patients: patients of the bariatric weight loss clinic, weight loss of 7% body mass via intentional weight loss within past 6 months; BMI \>25 kg/m2 prior to intentional weight loss; stable for 3 months on medications.
  • Lifestyle weight loss: weight loss of 7% body mass via intentional weight loss within past 6 months; BMI \>25 kg/m2 prior to intentional weight loss.

You may not qualify if:

  • Uncontrolled cardiovascular, metabolic, renal, or pulmonary disease; cancer treatment in past 5 years; untreated thyroid disease or other medical condition affecting weight or energy metabolism; severe food allergies; women who are pregnant, lactating, or planning pregnancy during participation in the trial; active psychiatric issues
  • Additional criteria specific to patients with history of bariatric surgery: \<12 months post-op; weight regain of \>5% of body mass postoperation; history of admittance to rehabilitation facility; history of post-op complications that require recent inpatient management; patients who were required to stay in the hospital \>1 week post-op; revision surgery patients; heart failure patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah

Salt Lake City, Utah, 84112, United States

Location

MeSH Terms

Conditions

Weight LossWeight GainFeeding BehaviorObesity

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior, AnimalBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Limitations and Caveats

This was a pilot and feasibility trial with a relatively small and non-diverse sample. We included patients who had experienced weight loss via diet/exercise, medication, and bariatric surgery. Due to the quasi-experimental design, we were not able to randomize based on weight loss modality which resulted in a severely skewed sample with most patients who reported to be on weight loss medications to be allocated to the BWI comparison group.

Results Point of Contact

Title
Tanya Halliday, PhD, RD
Organization
University of Utah

Study Officials

  • Tanya Halliday

    University of Utah

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 13, 2021

First Posted

April 19, 2021

Study Start

June 16, 2021

Primary Completion

May 8, 2023

Study Completion

May 22, 2024

Last Updated

November 25, 2025

Results First Posted

November 25, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations